There is a group of independent investigators at OSU with interests that span basic, preclinical and clinical aspects of brain tumor research. Funds from this Feasibility Grant plus considerable institutional support (contingent upon funding for this grant) will permit our group to establish three major components essential to develop into a cohesive Center with the theme of """"""""glioma growth control"""""""". For the first 3 years (Phase I) the major goals are the following: 1. Support interactive research projects of three new investigators who are bringing necessary breadth and depth to the group's expertise in the areas of molecular biology, flow cytometry, and epidemiology. These projects are all designed to develop the Center's theme of """"""""glioma growth control"""""""", and they will be used as a test system for the Neuro-Oncology Translator and Information System. 2. Develop a Neuro-Oncology Translator and Information System that will provide easy access and sharing of data among distributed, heterogeneous neuro-oncology databases. It will be tested with data generated from the three new, interactive research projects and heterogeneous databases distributed throughout the neuro-oncology community as OSU. By the end of Phase-I, it will be functional within our Center and ready to distribute to other institutions, permitting easy sharing of data among collaborating Brain Tumor Research Centers. 3. Establish three core units (Molecular Biology; Neuropathology; Biostatistics) that will provide needed support to all of the new and several established research projects studying glioma growth control. The addition of these components to the existing excellent clinical and research facilities in a rich academic milieu will provide the essential ingredients to transform a group of independent investigators and clinicians with a common interest in glioma growth control into a coordinated, integrated Brain Tumor Research Center.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory Grants (P20)
Project #
1P20NS031087-01
Application #
3100820
Study Section
Special Emphasis Panel (SRC (44))
Project Start
1992-09-01
Project End
1995-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Schwartzbaum, J A; Cornwell, D G (2000) Oxidant stress and glioblastoma multiforme risk: serum antioxidants, gamma-glutamyl transpeptidase, and ferritin. Nutr Cancer 38:40-9
Schwartzbaum, J A; Lal, P; Evanoff, W et al. (1999) Presurgical serum albumin levels predict survival time from glioblastoma multiforme. J Neurooncol 43:35-41
Schwartzbaum, J A; Fisher, J L; Goodman, J et al. (1999) Hypotheses concerning roles of dietary energy, cured meat, and serum tocopherols in adult glioma development. Neuroepidemiology 18:156-66
Mamrak, S A; Yates, A J (1997) An information system to support collaborative brain-tumor research. Brain Tumor Pathol 14:131-7
Sung, C C; Collins, R; Li, J et al. (1996) Glycolipids and myelin proteins in human oligodendrogliomas. Glycoconj J 13:433-43
Newton, H B; Rea, G L (1996) Lhermitte's sign as a presenting symptom of primary spinal cord tumor. J Neurooncol 29:183-8
Zhu, L; Zhu, L; Xie, E et al. (1995) Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell Biol 15:3552-62
Myers, R L; Chedid, M; Tronick, S R et al. (1995) Different fibroblast growth factor 1 (FGF-1) transcripts in neural tissues, glioblastomas and kidney carcinoma cell lines. Oncogene 11:785-9
Newton, H B; Newton, C L (1995) Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma. J Neurooncol 24:285-92
Newton, H B; Newton, C; Pearl, D et al. (1994) Swallowing assessment in primary brain tumor patients with dysphagia. Neurology 44:1927-32